Information about the autoantigens targeted by monoclonal Igs has been obtained from studies of rare symptomatic monoclonal gammopathies, called monoclonal gammopathies of clinical significance (MGCS) (46, 47). This evidence concerns the gene CUBN and monoclonal gammopathy.